Accumulating evidence confirms that CD274 promoter methylation determines PD-L1 expression and predicts the survival of melanoma patients, NSCLC, head, and neck squamous cell carcinomas (HNSCC) CRC [29–32]. The gene discussed is CD274; the disease is melanoma.